Specifically, phthalates have been described as agonists of the estrogen receptors (ER), and estrogens are linked to insulin resistance; thus, phthalates can promote insulin signaling through ERα mediated pathways, which, when sustained, may lead to excess insulin release, β-cell exhaustion, and peripheral insulin resistance [30]. The gene discussed is ESR1; the disease is Insulin resistance.